SILDENAFIL - 18 Annonces

Tuesday 09 December 2025

Testosterone Enanthate ivy@pharmade.com Raw Steroid Powder Safe Shipping Worldwide Email: ivy@pharmade.com Skype: 100powder WhatsApp: +86 17722691890 Testosterone Enanthate Muscle Growth Anabolic Steroid Powder Test En Keywords: Testosterone Enanthate, Testosterone, Enanthate, Testosterone...

Tuesday 15 July 2025

The introduction of the oral phosphodiesterase type 5 (PDE5) inhibitor sildenafil citrate (trade name: ) opened a new chapter in the history of erectile dysfunction (ED) treatment. Since Sildenafil citrate was approved by the US Food and Drug Administration (FDA) in March 1998,...

Tuesday 15 July 2025

Tadalafil (market name “Cialis” or “Adcirca”) was developed by American pharmaceutical company Lilly. It is a kind of PDE5 inhibitor used for the treatment of erectile dysfunction, benign prostatic hypertrophy and pulmonary arterial hypertension.The effect of Tadalafil is relaxing...

Tuesday 08 July 2025

Tadalafil (market name “Cialis” or “Adcirca”) was developed by American pharmaceutical company Lilly. It is a kind of PDE5 inhibitor used for the treatment of erectile dysfunction, benign prostatic hypertrophy and pulmonary arterial hypertension.The effect of Tadalafil is relaxing...

Thursday 03 July 2025

Tadalafil (market name “Cialis” or “Adcirca”) was developed by American pharmaceutical company Lilly. It is a kind of PDE5 inhibitor used for the treatment of erectile dysfunction, benign prostatic hypertrophy and pulmonary arterial hypertension.The effect of Tadalafil is relaxing...

Friday 27 June 2025

Tadalafil (market name “Cialis” or “Adcirca”) was developed by American pharmaceutical company Lilly. It is a kind of PDE5 inhibitor used for the treatment of erectile dysfunction, benign prostatic hypertrophy and pulmonary arterial hypertension.The effect of Tadalafil is relaxing...

Tuesday 10 June 2025

Quantité : 1kg; 25kg;

The introduction of the oral phosphodiesterase type 5 (PDE5) inhibitor sildenafil citrate (trade name: ) opened a new chapter in the history of erectile dysfunction (ED) treatment. Since Sildenafil citrate was approved by the US Food and Drug Administration (FDA) in March 1998, the...

Saturday 07 June 2025

Tadalafil (market name “Cialis” or “Adcirca”) was developed by American pharmaceutical company Lilly. It is a kind of PDE5 inhibitor used for the treatment of erectile dysfunction, benign prostatic hypertrophy and pulmonary arterial hypertension.The effect of Tadalafil is relaxing...

Friday 06 June 2025

Quantité : 1kg; 25kg;

Tadalafil (market name “Cialis” or “Adcirca”) was developed by American pharmaceutical company Lilly. It is a kind of PDE5 inhibitor used for the treatment of erectile dysfunction, benign prostatic hypertrophy and pulmonary arterial hypertension.The effect of Tadalafil is relaxing...

Friday 16 May 2025

The introduction of the oral phosphodiesterase type 5 (PDE5) inhibitor sildenafil citrate (trade name: ) opened a new chapter in the history of erectile dysfunction (ED) treatment. Since Sildenafil citrate was approved by the US Food and Drug Administration (FDA) in March 1998, the...

Friday 16 May 2025

Tadalafil (market name “Cialis” or “Adcirca”) was developed by American pharmaceutical company Lilly. It is a kind of PDE5 inhibitor used for the treatment of erectile dysfunction, benign prostatic hypertrophy and pulmonary arterial hypertension.The effect of Tadalafil is relaxing...

Tuesday 08 April 2025

Tadalafil (market name “Cialis” or “Adcirca”) was developed by American pharmaceutical company Lilly. It is a kind of PDE5 inhibitor used for the treatment of erectile dysfunction, benign prostatic hypertrophy and pulmonary arterial hypertension.The effect of Tadalafil is relaxing...

Tuesday 08 April 2025

Quantité : 9999 - Prix : 1,00 €

The introduction of the oral phosphodiesterase type 5 (PDE5) inhibitor sildenafil citrate (trade name: ) opened a new chapter in the history of erectile dysfunction (ED) treatment. Since Sildenafil citrate was approved by the US Food and Drug Administration (FDA) in March 1998, the...

Thursday 03 April 2025

The introduction of the oral phosphodiesterase type 5 (PDE5) inhibitor sildenafil citrate (trade name: ) opened a new chapter in the history of erectile dysfunction (ED) treatment. Since Sildenafil citrate was approved by the US Food and Drug Administration (FDA) in March 1998, the...

Thursday 03 April 2025

Tadalafil (market name “Cialis” or “Adcirca”) was developed by American pharmaceutical company Lilly. It is a kind of PDE5 inhibitor used for the treatment of erectile dysfunction, benign prostatic hypertrophy and pulmonary arterial hypertension.The effect of Tadalafil is relaxing...

Saturday 29 March 2025

The introduction of the oral phosphodiesterase type 5 (PDE5) inhibitor sildenafil citrate (trade name: ) opened a new chapter in the history of erectile dysfunction (ED) treatment. Since Sildenafil citrate was approved by the US Food and Drug Administration (FDA) in March 1998, the...

Wednesday 19 March 2025

Tadalafil (market name “Cialis” or “Adcirca”) was developed by American pharmaceutical company Lilly. It is a kind of PDE5 inhibitor used for the treatment of erectile dysfunction, benign prostatic hypertrophy and pulmonary arterial hypertension.The effect of Tadalafil is relaxing...

Friday 15 January 2016

- Product name: L-Arginine - CAS No.: 1119-34-2 Appearance: White crystalline powder Assay: 98.5% ~ 101.5% Packing: 25kg/drum Storage: kept in dry, cool, and shaded place with original packaging, avoid moisture. Shelf life: 24 months Main function: 1. Blood vessel function...